Cointime

Turnstone Biologics

company

About

Turnstone Biologics is a privately-held clinical stage biotech company.

  • 51 - 100

Highlights

Total Funding Amount
$132.69M
Funding Rounds
4
Investors
3

Details

Last Funding Type
Corporate Round
Industries
Biotechnology,Innovation Management,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
51 - 100
Operating Status
Active

Turnstone Biologics is a privately-held clinical-stage biotech company. Turnstone Biologics’ mission is to deliver breakthrough cancer immunotherapies by advancing two leading and complementary platforms targeting tumor immunity, to improve survival for people with cancer.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$132.69M
Turnstone Biologics has raised a total of $132.69M in funding over 2 rounds. Their latest funding was raised on Jul 14, 2021 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 14, 2021 Series D $79.99M 2 — — Detail
Dec 19, 2019 Corporate Round — 1 Takeda — Detail
Nov 2, 2016 Series B $41.40M 1 — — Detail
Oct 27, 2015 Series A $11.30M 1 Versant Ventures — Detail

Investors

Number of Lead Investors
Number of Investors
2
3
Turnstone Biologics is funded by 3 investors. Takeda and Northleaf Capital Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Takeda Yes Corporate Round
Northleaf Capital Partners — Series D
Versant Ventures — Series D
Cointime
เนื้อหา
บริษัท